Epigenetics in health and disease

L Zhang, Q Lu, C Chang - Epigenetics in allergy and autoimmunity, 2020 - Springer
Epigenetic mechanisms, which include DNA methylation, histone modification, and
microRNA (miRNA), can produce heritable phenotypic changes without a change in DNA …

The landscape of the mesenchymal signature in brain tumours

J Behnan, G Finocchiaro, G Hanna - Brain, 2019 - academic.oup.com
The complexity of glioblastoma multiforme, the most common and lethal variant of gliomas,
is reflected by cellular and molecular heterogeneity at both the inter-and intra-tumoural …

Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma

KPL Bhat, V Balasubramaniyan, B Vaillant… - Cancer cell, 2013 - cell.com
Despite extensive study, few therapeutic targets have been identified for glioblastoma
(GBM). Here we show that patient-derived glioma sphere cultures (GSCs) that resemble …

Emerging insights into the molecular and cellular basis of glioblastoma

GP Dunn, ML Rinne, J Wykosky… - Genes & …, 2012 - genesdev.cshlp.org
Glioblastoma is both the most common and lethal primary malignant brain tumor. Extensive
multiplatform genomic characterization has provided a higher-resolution picture of the …

β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion

L Du, JH Lee, H Jiang, C Wang, S Wang… - Journal of Experimental …, 2020 - rupress.org
PD-L1 up-regulation in cancer contributes to immune evasion by tumor cells. Here, we show
that Wnt ligand and activated EGFR induce the binding of the β-catenin/TCF/LEF complex to …

microRNAs (miRNAs) in glioblastoma multiforme (GBM)—recent literature review

M Makowska, B Smolarz, H Romanowicz - International Journal of …, 2023 - mdpi.com
Glioblastoma multiforme (GBM) is the most common, malignant, poorly promising primary
brain tumor. GBM is characterized by an infiltrating growth nature, abundant vascularization …

Molecular and cellular heterogeneity: the hallmark of glioblastoma

DJ Aum, DH Kim, TL Beaumont, EC Leuthardt… - Neurosurgical …, 2014 - thejns.org
There has been increasing awareness that glioblastoma, which may seem
histopathologically similar across many tumors, actually represents a group of molecularly …

Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment

N Pandey, P Anastasiadis, CP Carney… - Advanced drug delivery …, 2022 - Elsevier
Glioblastoma (GBM) is the most common malignant adult brain cancer with no curative
treatment strategy. A significant hurdle in GBM treatment is effective therapeutic delivery to …

E2F7− EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression

R Yang, M Wang, G Zhang, Y Bao, Y Wu, X Li… - British journal of …, 2020 - nature.com
Background E2F transcription factors are considered to be important drivers of tumour
growth. E2F7 is an atypical E2F factor, and its role in glioblastoma remains undefined …

Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment

A Mafi, A Rahmati, Z Babaei Aghdam, R Salami… - Cellular & Molecular …, 2022 - Springer
Gliomas are the most lethal primary brain tumors in adults. These highly invasive tumors
have poor 5-year survival for patients. Gliomas are principally characterized by rapid …